Chapel Hill, NC, United States of America

Dustin Cashman

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Dustin Cashman

Introduction

Dustin Cashman is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of bioreactor technology, holding a total of 3 patents. His work focuses on systems and methods that enhance the cultivation of biological matter.

Latest Patents

One of his latest patents is a "Drawer system for cultivating tissue." This invention involves a bioreactor that includes a drawer cage and multiple drawers designed to contain bioreactors for cultivating biological matter. The system is equipped with a platform that allows the drawer cage to rotate or tilt, optimizing the cultivation process.

Another notable patent is for a "System, apparatuses, devices and methods for straining a cultivated tissue." This invention features a pulsing system that provides pressure pulses to a fluid communication tube connected to a bioreactor. The system includes various components such as pulsing motors and fluid communication tubes, which work together to create temporary pressure increases in the bioreactor, facilitating the cultivation of tissue.

Career Highlights

Dustin Cashman is currently employed at Humacyte, Inc., where he continues to innovate in the field of bioreactor technology. His work has the potential to significantly impact the medical field, particularly in tissue engineering and regenerative medicine.

Collaborations

Dustin collaborates with talented individuals such as Heather L. Prichard and Joshua McCall, contributing to a dynamic team focused on advancing biotechnological solutions.

Conclusion

Dustin Cashman is a notable inventor whose work in bioreactor technology is paving the way for advancements in tissue cultivation. His innovative patents and contributions to Humacyte, Inc. highlight his commitment to improving biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…